These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10727885)

  • 1. Novel bacterial systems for the delivery of recombinant protein or DNA.
    Spreng S; Dietrich G; Niewiesk S; ter Meulen V; Gentschev I; Goebel W
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):299-304. PubMed ID: 10727885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of protein antigens and DNA by attenuated intracellular bacteria.
    Gentschev I; Dietrich G; Spreng S; Pilgrim S; Stritzker J; Kolb-Mäurer A; Goebel W
    Int J Med Microbiol; 2002 Feb; 291(6-7):577-82. PubMed ID: 11890559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant attenuated bacteria for the delivery of subunit vaccines.
    Gentschev I; Dietrich G; Spreng S; Kolb-Mäurer A; Brinkmann V; Grode L; Hess J; Kaufmann SH; Goebel W
    Vaccine; 2001 Mar; 19(17-19):2621-8. PubMed ID: 11257401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of protein antigens and DNA by virulence-attenuated strains of Salmonella typhimurium and Listeria monocytogenes.
    Gentschev I; Dietrich G; Spreng S; Kolb-Mäurer A; Daniels J; Hess J; Kaufmann SH; Goebel W
    J Biotechnol; 2000 Sep; 83(1-2):19-26. PubMed ID: 11000455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
    Zhu C; Ruiz-Perez F; Yang Z; Mao Y; Hackethal VL; Greco KM; Choy W; Davis K; Butterton JR; Boedeker EC
    Vaccine; 2006 May; 24(18):3821-31. PubMed ID: 16098637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes.
    Dietrich G; Bubert A; Gentschev I; Sokolovic Z; Simm A; Catic A; Kaufmann SH; Hess J; Szalay AA; Goebel W
    Nat Biotechnol; 1998 Feb; 16(2):181-5. PubMed ID: 9487527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of attenuated bacteria as delivery vectors for DNA vaccines.
    Daudel D; Weidinger G; Spreng S
    Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gram-positive and Gram-negative bacteria as carrier systems for DNA vaccines.
    Dietrich G; Kolb-Mäurer A; Spreng S; Schartl M; Goebel W; Gentschev I
    Vaccine; 2001 Mar; 19(17-19):2506-12. PubMed ID: 11257384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
    Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
    Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI; Schoen CU; Goebel W; Pilgrim S
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial systems for the delivery of eukaryotic antigen expression vectors.
    Dietrich G; Spreng S; Gentschev I; Goebel W
    Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):391-9. PubMed ID: 11079578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and future perspectives of DNA vaccine delivery by attenuated intracellular bacteria.
    Dietrich G
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):177-82. PubMed ID: 10912622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated Listeria monocytogenes, a Mycobacterium tuberculosis ESAT-6 antigen expression and delivery vector for inducing an immune response.
    Yin Y; Tian D; Jia Y; Gao Y; Fu H; Niu Z; Sun L; Jiao X
    Res Microbiol; 2012; 163(8):540-9. PubMed ID: 22835946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Listeria monocytogenes-based antibiotic resistance gene-free antigen delivery system applicable to other bacterial vectors and DNA vaccines.
    Verch T; Pan ZK; Paterson Y
    Infect Immun; 2004 Nov; 72(11):6418-25. PubMed ID: 15501772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral somatic transgene vaccination using attenuated S. typhimurium.
    Darji A; Guzmán CA; Gerstel B; Wachholz P; Timmis KN; Wehland J; Chakraborty T; Weiss S
    Cell; 1997 Dec; 91(6):765-75. PubMed ID: 9413986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier.
    Darji A; zur Lage S; Garbe AI; Chakraborty T; Weiss S
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):341-9. PubMed ID: 10727890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of mice with attenuated mutants of Listeria monocytogenes: requirement for induction of macrophage la expression.
    Gahan CG; Collins JK
    Microb Pathog; 1995 Jun; 18(6):417-22. PubMed ID: 8551944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic immunization of mice against Listeria monocytogenes using plasmid DNA encoding listeriolysin O.
    Cornell KA; Bouwer HG; Hinrichs DJ; Barry RA
    J Immunol; 1999 Jul; 163(1):322-9. PubMed ID: 10384131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathway.
    Gentschev I; Mollenkopf H; Sokolovic Z; Hess J; Kaufmann SH; Goebel W
    Gene; 1996 Nov; 179(1):133-40. PubMed ID: 8955639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmid maintenance systems suitable for GMO-based bacterial vaccines.
    Spreng S; Viret JF
    Vaccine; 2005 Mar; 23(17-18):2060-5. PubMed ID: 15755571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.